vVARDIS Holding AG (VVVV)
Company
vVARDIS Holding AG (VVVV)
Nov 13, 2026
Health
Initial Public Offering / IPODrawing on extensive industry experience, market understanding and clinical evidence, Curodont® is a first-in-category healthcare platform: the first clinically validated treatment for early-stage cavities designed to preserve natural tooth structure and restore enamel crystal density throughout the lesion, in a process similar to natural tooth formation. This proprietary peptide-enabled technology offers an early therapeutic approach to tooth decay—the world’s most prevalent non-communicable disease—and addresses a substantial global healthcare need where effective medical options for early intervention have historically been limited.







